Clinical trialNCT00247416CompletedPhase 2Interventional

Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer

SponsorSusanne ArnoldEnrollment60Stage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to find better treatment for lung cancer and to find out what effects the combined treatment of carboplatin and gemcitabine when given with or without dexamethasone have on cancer. This study will determine if dexamethasone, when given before standard chemotherapy will increase the cancer fighting effects and reduce the side effects of chemotherapy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

John Rinehart
Lucille P. Markey Cancer Center at University of Kentucky
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Commonwealth Cancer Center
Danville, Kentucky, United States
Markey Cancer Center
Lexington, Kentucky, United States
Brown Cancer Center
Louisville, Kentucky, United States
St. Claire Regional Medical Center
Morehead, Kentucky, United States
Montgomery Cancer Center
Mount Sterling, Kentucky, United States
Owensboro Medical Healthcare System
Owensboro, Kentucky, United States
West Kentucky Hematology & Oncology Group, Psc
Paducah, Kentucky, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Carboplatin →Dexamethasone →Gemcitabine →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Aug 2005
Primary completion: 31 Jul 2009
Completion: 31 Jul 2009
Last update posted: 7 Mar 2014
Registered enrollment: 60
Registry id: NCT00247416

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.